Jonathan Leith

Full Development Team Lead
Hematology
BristolMyers Squibb
United States of America

Biography

Full Development Team Lead - all hematology assets including OPDIVO, SPRYCEL and EMPLICITI - accountable for all R&D aspects of strategy and development across immuno-oncology and oncology assets. - core hematology indications include Chronic Myelogenous Leukemia, Multiple Myeloma and Lymphomas. - translational research, new indications and combinations, exploratory R&D - LCM development for key assets.

Research Interest

business

Global Experts from United States of America

Global Experts in Subject

Share This Profile

Recent Expert Updates

Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. R Sameh
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. William
pediatrics
Maimonides Medical Center
United States of America